Nuran Ercal

Title: Nuran Ercal: Innovator in Radiosensitizer Formulations

Introduction

Nuran Ercal is a prominent inventor based in Rolla, MO (US). She has made significant contributions to the field of radiosensitizer formulations, which are crucial in enhancing the effectiveness of radiotherapy for cancer treatment. Her innovative work focuses on developing controlled-release formulations that can improve patient outcomes.

Latest Patents

Nuran Ercal holds a patent for "Radiosensitizer formulations and methods for use." This invention provides radiosensitizer compositions, particularly nitrohistidine radiosensitizer compositions, which can be administered through various means, including oral and intravenous methods. The formulations may also be combined with other agents, such as chemotherapy drugs, to create a synergistic effect. The patent outlines methods for potentiating radiotherapy in treating cancers, especially astrocytomas, by administering a radiosensitizer composition alongside targeted radiotherapy.

Career Highlights

Throughout her career, Nuran Ercal has demonstrated a commitment to advancing cancer treatment methodologies. Her research has focused on improving the efficacy of radiotherapy, which is vital for patients battling various forms of cancer. Her innovative approaches have garnered attention in the medical and scientific communities.

Collaborations

Nuran has collaborated with notable colleagues, including Richard H Matthews and Robert Zand. These partnerships have contributed to her research and the development of her patented formulations.

Conclusion

Nuran Ercal's work in radiosensitizer formulations represents a significant advancement in cancer treatment. Her innovative approaches and dedication to improving patient care continue to make a positive impact in the field of oncology.